Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
(PubMed) Nishimune T, Watanabe Y, Okazaki H, Akai H
Two new studies led by researchers at the University of Chicago found that although GLP-1 drugs deliver impressive long-term health improvements, their current prices far exceed accepted thresholds for cost-effectiveness, posing difficult choices for policymakers, insurers and patients
doi: 10.3389/fpsyt.2018.00784 36 DarsaliaV.MansouriS.OrtsaterH.OlverlingA.NozadzeN.KappeC.et al
Similar content being viewed by others Introduction Diminished growth hormone (GH) and insulin/insulin-like growth factor-1 (IGF-1) signaling extends lifespan in many laboratory models, including mutations to daf2 in worms 1 , Sch9 in yeast 2 , and Chico in drosophila 3
